Skip to main content
Clinical Trials/NCT02576106
NCT02576106
Completed
Not Applicable

Evaluation of Percutaneous Treatment by Cryoablation of Unifocal Invasive Breast Carcinoma in Menopausal Women With Indication of Lumpectomy

Centre Leon Berard1 site in 1 country22 target enrollmentFebruary 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Carcinoma, Ductal, Breast
Sponsor
Centre Leon Berard
Enrollment
22
Locations
1
Primary Endpoint
The rate of success of cryoablation procedure
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The primary objective of this monocentric and feasibility study is to review the efficacy of cryotherapy in the treatment of unifocal mammary carcinomas in post-menopausal patients, with lumpectomy indication.

The efficacy is defined by the rate of success of cryotherapy procedures. For each one of those evaluated process, an success will be defined on the tumor sample of lumpectomy by the absence of viable tumour cells.

On the basis of our expertise, it seems interesting to propose this experimental procedure to patients as described above.

Registry
clinicaltrials.gov
Start Date
February 2016
End Date
January 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Single Group
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Non inflammatory unilateral and unifocal breast cancer with indication of lumpectomy
  • Menopausal women with age \> 55 years
  • Tumor size \<= 15 mm by ultrasonography
  • Histological confirmation (by biopsy) of invasive ductal carcinoma with SBR (Scarff-Bloom-Richardson) grade (modified by Ellis \& Elston) 1 or 2; hormone receptors positive (Estrogen Receptor and/or Progesterone Receptor) and negative Human epidermal growth factor receptor (HER2)
  • Good lesion boundary with ultrasonography and MRI
  • Minimal distance of 5 mm between the skin and the tumor
  • Performance Status 0-1
  • Ability to understand and willingness to sign a written informed consent document
  • Covered by a medical insurance
  • Signed informed consent

Exclusion Criteria

  • Invasive lobular carcinoma
  • Tumor with retro-nipple location
  • Extended microcalcifications (\> 15 mm) with mammography
  • Xylocaine allergy
  • Patient deprived of freedom

Outcomes

Primary Outcomes

The rate of success of cryoablation procedure

Time Frame: 45 days after cryoablation

percentage of viable cells in the piece of lumpectomy

Study Sites (1)

Loading locations...

Similar Trials